FDA approves Neurocrine Biosciences Crenessity to be used with glucocorticoids to control androgen in adult and some pediatric patients with classic c...
FDA says Endo USA has recalled its Adrenalin Chloride Solution that predates the Federal Food, Drug, and Cosmetic Act and was never submitted for FDA ...
FDA warns four companies it says are marketing unapproved copies of popular weight loss drugs.
FDA publishes an updated Global Unique Device Identification Database guidance.
FDA approves Hikmas liraglutide injection, the first generic form of Novo Nordisks Victoza it has approved.
FDA approves an expanded indication for Rhythms Imcivree to include pediatric patients as young as age 2.
FDA approves Ionis Tryngolza as an adjunct to diet to reduce triglycerides in adults with familial chylomicronemia syndrome.
FDA says it has completed its evaluation of several adverse effects found in dogs treated with Librela for pain associated with osteoarthritis.
